Telehealth

Technology has transformed healthcare and dentistry through innovations like digital imaging, 3D printing, and artificial intelligence, with telehealth expanding during the pandemic. The Biden administration's 2024 initiative highlights AI's potential in healthcare.

North Carolina senators advanced House Bill 1104, which shifts psychiatric evaluations for suspects in custody from emergency rooms to jails. The bill aims to address safety concerns in hospitals and aligns with Iryna’s Law, which increased pretrial detentions and psychiatric assessments.

Overdoses involving GLP-1s are increasing due to their easier availability through telehealth services, which often bypass traditional in-person medical consultations and pharmacies.

Telehealth access to abortion pills is critical for domestic violence survivors, as highlighted by two women who relied on medication abortions to escape abusive relationships. A Louisiana lawsuit challenges the FDA's 2023 rule allowing telehealth prescriptions of mifepristone, a drug used for early pregnancy termination, while advocates stress its importance for discreet care.

Telehealth companies like Hims & Hers and Teladoc have grown into a multi-billion-dollar industry, but face legal challenges in over 30 states where corporations are prohibited from practicing medicine. To comply, these companies partner with independent medical groups owned by physicians who hold multiple state licenses, ensuring clinical decisions prioritize patient needs over corporate profits.

GLP-1 users are turning to telehealth services to access weight loss drugs, providing a convenient and accessible way to manage their weight. This shift towards telehealth highlights the growing demand for remote healthcare solutions. The trend is expected to continue as more people seek online health services.

Courts may restrict access to mifepristone, a popular abortion medication in the US, but telehealth providers have backup plans. This restriction could impact abortion access, and telehealth services are preparing alternatives. Mifepristone is a key medication used for abortions.

The Supreme Court has been asked to pause a ruling that restricts telehealth and mail access to abortion pills. Danco Laboratories, the manufacturer of mifepristone, argues the lower court's decision to immediately limit the drug's sale to in-person distribution was excessive.

Danco Laboratories, the manufacturer of Mifepristone, has petitioned the Supreme Court to block a federal appeals court ruling that prohibits telehealth prescriptions and mail dispensing of the abortion pill. The company filed an emergency motion seeking to overturn the restrictions imposed by the lower court.

Democrats are criticizing a court ruling that blocked telehealth prescriptions and mail delivery of the abortion pill mifepristone, arguing it will limit reproductive care. Rep. Ayanna Pressley condemned the decision by 'Trump-appointed extremists' as an attack on medication abortion access.

A federal appeals court blocked mail-order prescriptions of the abortion pill mifepristone, restricting access through telehealth. The 5th U.S. Circuit Court of Appeals sided with Louisiana in a lawsuit against the FDA, issuing a temporary nationwide injunction.

A federal appeals court ruled that the abortion drug mifepristone cannot be mailed to patients, impacting telehealth access. This decision follows the Supreme Court's 2022 overturning of Roe v. Wade, which led to abortion restrictions in many states.

A federal appeals court blocked telehealth prescriptions and mail delivery of the abortion pill mifepristone, siding with Louisiana in a lawsuit against the FDA. The 5th U.S. Circuit Court of Appeals issued a temporary nationwide injunction, restricting abortion access.

An appeals court has halted nationwide access to abortion pills via telehealth and mail. The decision affects the distribution of mifepristone, a medication used for early-stage abortions, which was previously available through remote consultations and home delivery.